"I want to share my story and help others like myself living with MPN. MPN Research Foundation has been that source of community support for my family and I as we learn to deal with living with a disease on a daily basis."

News

Help me find

Jakavi approved in Europe

In August 2012 Jakavi - the European name for Jakafi - was approved for use in Myelofibrosis patients throughout Europe. Jakafi was approved by the FDA in January 2012. This marks the first European Commission approved treatment for symptoms related to myelofibrosis. To read more about the approval click here.

 

Your donation goes a long way.

Learn more about how you can help support the MPN Research Foundation and the impact your contributions can make.

Donate Now
 
 
 

Subscribe

Want to learn more about the MPN Research Foundation? Sign up for our Newsletter and Research Alerts!

Newsletter Signup

 
 

Connect with Us

MPN Research Foundation wants to hear from you. Connect with us through our social networks or send us an email.

Email Facebook Twitter LinkedIn